Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.
Covering analysts: Bank of America Securities, Bernstein Research, Blue Oar Securities, Caris & Company, Charles Stanley & Co, Citigroup Investment Research, Collins Stewart, Deutsche Bank Research, Exane BNP Paribas, Goldman Sachs, IIR Group, Jefferies, JP Morgan, Lehman Bros, Merrill Lynch, Morgan Stanley, Natixis Securities, Panmure Gordon, RBC Capital Markets, Robert W. Baird & Co, Société Générale, Standard & Poors, Susquehanna Financial Group, WestLB Equity Markets